ArticleDiabetologia2026

Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes.

Stephen E Gitelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.